Aging of platelets stored for transfusion.

about

Preparation of Platelet Concentrates for Research and Transfusion Purposes.Platelet components: is there need or room for quality control assays of storage lesions?

P2860

Q33443256-AE6028E2-B4E2-4FAF-9580-DF2A1D825E11 Q49326372-26465F6E-2F1F-406B-A872-F55F3AC426D2

P2860

Aging of platelets stored for transfusion.

Item

http://www.wikidata.org/entity/Q38822804

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Aging of platelets stored for transfusion.

@en

type

Item

label

Aging of platelets stored for transfusion.

@en

prefLabel

Aging of platelets stored for transfusion.

@en

P1476

Aging of platelets stored for transfusion.

@en

P2093

Peter A Smethurst

http://www.w3.org/2001/XMLSchema#string

P2860

Dose of prophylactic platelet transfusions and prevention of hemorrhage

High shear-dependent loss of membrane integrity and defective platelet adhesion following disruption of the GPIbα-filamin interaction

Guidelines for the use of platelet transfusions.

The quantitative relation between platelet count and hemorrhage in patients with acute leukemia.

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.

Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.

Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia.

A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology.

P304

526-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09537104.2016.1171303

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27135140

http://www.w3.org/2001/XMLSchema#string

Aging of platelets stored for transfusion.

about

P2860

P2860

Aging of platelets stored for transfusion.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698